Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Invested Capital: 2009-2024

Historic Invested Capital for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to -$301.3 million.

  • Ironwood Pharmaceuticals' Invested Capital rose 79.23% to -$64.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.7 million, marking a year-over-year increase of 79.23%. This contributed to the annual value of -$301.3 million for FY2024, which is 105.36% down from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Invested Capital stood at -$301.3 million for FY2024, which was down 105.36% from -$146.7 million recorded in FY2023.
  • Ironwood Pharmaceuticals' 5-year Invested Capital high stood at $722.8 million for FY2021, and its period low was -$301.3 million during FY2024.
  • Its 3-year average for Invested Capital is $68.1 million, with a median of -$146.7 million in 2023.
  • In the last 5 years, Ironwood Pharmaceuticals' Invested Capital spiked by 1,053.85% in 2021 and then crashed by 122.49% in 2023.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' Invested Capital stood at $62.6 million in 2020, then surged by 1,053.85% to $722.8 million in 2021, then decreased by 9.74% to $652.4 million in 2022, then plummeted by 122.49% to -$146.7 million in 2023, then crashed by 105.36% to -$301.3 million in 2024.